Impaired Cd14 and Cd36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice

Shock

Volumn 35, Issue 1, 2011, Pages 92-99

  Tsai, Tsung Huang ^a,b   Chen, Shu Fen ^b   Huang, Tai Yu ^b   Tzeng, Chun Fu ^b   Chiang, Ann Shyn ^a   Kou, Yu Ru ^c   Lee, Tzong Shyuan ^c   Shyue, Song Kun ^b,d  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Caveolin 1; macrophage; MyD88; phagocytosis; Toll like receptor 4

Indexed keywords

CAVEOLIN 1; CD14 ANTIGEN; CD36 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL CLEARANCE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREGULATION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD36; CAVEOLIN 1; CELL LINE; CELLS, CULTURED; ESCHERICHIA COLI; FLOW CYTOMETRY; IMMUNOBLOTTING; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 78650790463     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181ea45ca     Document Type: Article

References (34)

1. Munford RS: Severe sepsis and septic shock: the role of gram-negative bac-teremia. Annu Rev Pathol 1:467-496, 2006.
2. Stuart LM, Ezekowitz RA: Phagocytosis: elegant complexity. Immunity 22: 539-550, 2005.
3. Pluddemann A, Neyen C, Gordon S: Macrophage scavenger receptors and host-derived ligands. Methods 43:207-217, 2007.
4. Febbraio M, Hajjar DP, Silverstein RL: CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785-791, 2001.
5. Stuart LM, Deng J, Silver JM, Takahashi K, Tseng AA, HennesS- EJ, Ezekowitz RA, Moore KJ: Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 170:477-485, 2005.
6. Baranova IN, Kurlander R, Bocharov AV, Vishnyakova TG, Chen Z, Remaley AT, Csako G, Patterson AP, Eggerman TL: Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol 181:7147-7156, 2008.
7. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM: Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414, 1996.
8. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS: Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 165:5780-5787, 2000.
9. West AP, Koblansky AA, Ghosh S: Recognition and signaling by Toll-like receptors. Annu Rev Cell Dev Biol 22:409-437, 2006.
10. Liu P, Rudick M, Anderson RG: Multiple functions of caveolin-1. J Biol Chem 277:41295-41298, 2002.
11. Shin JS, Gao Z, Abraham SN: Involvement of cellular caveolae in bacterial entry into mast cells. Science 289:785-788, 2000.
12. Pelkmans L, Kartenbeck J, Helenius A: Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3:473-483, 2001.
13. Rodriguez NE, Gaur U, Wilson ME: Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell Microbiol 8:1106-1120, 2006.
14. Barrias ES, Dutra JM, De Souza W, Carvalho TM: Participation of macrophage membrane rafts in Trypanosoma cruzi invasion process. Biochem Biophys Res Commun 363:828-834, 2007.
15. Zaas DW, Duncan M, Rae Wright J, Abraham SN: The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta 1746:305-313, 2005. (Pubitemid 41815024)
16. Li J, Scherl A, Medina F, Frank PG, Kitsis RN, Tanowitz HB, Sotgia F, Lisanti MP: Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle 4:1599-1607, 2005.
17. Thomas-Ecker S, Lindecke A, Hatzmann W, Kaltschmidt C, Zanker KS, Ditt-mar T: Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells. Proc Natl Acad Sci USA 104:5539-5544, 2007.
18. Sklar MD, Tereba A, Chen BD, Walker WS: Transformation of mouse bone marrow cells by transfection with a human oncogene related to c-myc is associated with the endogenous production of macrophage colony stimulating factor 1. J Cell Physiol 125:403-412, 1985.
19. Chang TC, Huang CJ, Tam K, Chen SF, Tan KT, Tsai MS, Lin TN, Shyue SK: Stabilization of hypoxia-inducible factor-1{alpha} by prostacyclin under pro- longed hypoxia via reducing reactive oxygen species level in endothelial cells. J Biol Chem 280:36567-36574, 2005.
20. Liou JY, Deng WG, Gilroy DW, Shyue SK, Wu KK: Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem 276:34975-34982, 2001.
21. Philips JA, Rubin EJ, Perrimon N: Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309:1251-1253, 2005.
22. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, et al.: Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-736, 1999.
23. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Bolcskei PL, Wagner M, et al.: Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291:1544-1547, 2001.
24. Garrean S, Gao XP, Brovkovych V, Shimizu J, Zhao YY, Vogel SM, Malik AB: Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol 177:4853-4860, 2006.
25. Blander JM, Medzhitov R: Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014-1018, 2004.
26. Anderson RG: The caveolae membrane S-stem. Annu Rev Biochem 67: 199-225, 1998.
27. Gutierrez MG, Mishra BB, Jordao L, Elliott E, Anes E, Griffiths G: NF-kappa B activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages. J Immunol 181:2651-2663, 2008.
28. Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AM: The heme oxygenase-1/ carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 182:3809-3818, 2009.
29. Medina FA, Cohen AW, de Almeida CJ, Nagajyothi F, Braunstein VL, Teixeira MM, Tanowitz HB, Lisanti MP: Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain). Microbes Infect 9:325-333, 2007.
30. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ: Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA 95:13875-13880, 1998.
31. Barber RC, Maass DL, White DJ, Chang LY, Horton JW: Molecular or phar-macologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction. Shock 30:705-713, 2008.
32. Verbon A, Dekkers PE, ten Hove T, Hack CE, Pribble JP, Turner T, Souza S, Axtelle T, Hoek FJ, van Deventer SJ, et al.: IC14, an anti-CD14 antibody, inhibits endotoxin-mediated S-mptoms and inflammatory responses in humans. J Immunol 166:3599-3605, 2001.
33. Salomao R, Martins PS, Brunialti MK, Fernandes Mda L, Martos LS, Mendes ME, Gomes NE, Rigato O: TLR signaling pathway in patients with sepsis. Shock 30 (Suppl 1):73-77, 2008.
34. Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM: Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med 38:72-83, 2010.